Rep. Carol Devine Miller Stock Trades
Rep. Carol Devine Miller (U.S. House · WV03) has disclosed 14 congressional stock transactions under the Stop Trading on Congressional Knowledge (STOCK) Act between Mar 17, 2020 and Aug 14, 2026, including 1 purchases and 13 sales across 5 distinct stock tickers. Most-traded stocks include Quest Diagnostics Incorporated ($DGX), Pfizer Inc. ($PFE), Target Corporation ($TGT), U.S. Bancorp ($USB), Chevron Corporation ($CVX).
Hon. Carol Devine Miller sold four stocks on 03/10/2025: Pfizer Inc. (PFE), Quest Diagnostics (DGX), Target Corporation (TGT), and U.S. Bancorp (USB), each in the $15,001-$50,000 range, totaling approximately $60,004-$200,000 across all transactions.
Hon. Carol Devine Miller conducted 31 stock transactions totaling approximately $500,000+ across various blue-chip companies and consumer goods stocks in July-August 2020. Purchases included Abbott Laboratories, Amgen, Chevron, Cisco, Clorox, Corning, Dominion Energy, Dover, Emerson Electric, Hormel Foods, Iron Mountain, Johnson & Johnson, McDonald's, Procter & Gamble, U.S. Bancorp, Union Pacific, and Waste Management. Sales included AFLAC, Altria, Anheuser-Busch, Beacon Roofing, British American Tobacco, CVS Health, Energizer Holdings, Halliburton, Kraft Heinz, Mondelez, Spark Energy, and Yum China.
Rep. Carol Devine Miller (WV-03) conducted 10 stock transactions between December 2018 and August 2019, including purchases of ABBV, BTI, CVS, PFE, and KHC, and sales of CVX, EXC, MZOR, PSX, and QCOM, with most transactions valued between $15,001-$50,000.
| Stock / Asset | Action | Amount Range | Traded | Filing |
|---|---|---|---|---|
|
$TGT
Target Corporation
|
Sale (Full) | $15,001 - $50,000 | Mar 10, 2025 | PTR PDF ↗ |
|
$DGX
Quest Diagnostics Incorporated
|
Sale (Full) | $15,001 - $50,000 | Mar 10, 2025 | PTR PDF ↗ |
|
$PFE
Pfizer Inc.
|
Sale (Full) | $15,001 - $50,000 | Mar 10, 2025 | PTR PDF ↗ |
|
$USB
U.S. Bancorp
|
Sale (Full) | $15,001 - $50,000 | Mar 10, 2025 | PTR PDF ↗ |
|
$TGT
Target Corporation
|
Sale | $15,001 - $50,000 | Mar 10, 2025 | PTR PDF ↗ |
|
$PFE
Pfizer Inc.
|
Sale | $15,001 - $50,000 | Mar 10, 2025 | PTR PDF ↗ |
|
$USB
U.S. Bancorp
|
Sale | $15,001 - $50,000 | Mar 10, 2025 | PTR PDF ↗ |
|
$DGX
Quest Diagnostics Incorporated
|
Sale | $15,001 - $50,000 | Mar 10, 2025 | PTR PDF ↗ |
|
$PFE
Pfizer Inc.
|
Sale (Full) | $15,001 - $50,000 | Mar 9, 2025 | PTR PDF ↗ |
|
$TGT
Target Corporation
|
Sale (Full) | $15,001 - $50,000 | Mar 9, 2025 | PTR PDF ↗ |
|
$DGX
Quest Diagnostics Incorporated
|
Sale (Full) | $15,001 - $50,000 | Mar 9, 2025 | PTR PDF ↗ |
|
$USB
U.S. Bancorp
|
Sale (Full) | $15,001 - $50,000 | Mar 9, 2025 | PTR PDF ↗ |
|
$CVX
Chevron Corporation
|
Purchase | $15,001 - $50,000 | Aug 4, 2020 | PTR PDF ↗ |
|
$CVX
Chevron Corporation
|
Sale (Full) | $1,001 - $15,000 | Mar 17, 2020 | PTR PDF ↗ |